{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T19:06:23Z","timestamp":1775243183089,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004755","name":"University of Veterinary and Pharmaceutical Sciences Brno","doi-asserted-by":"publisher","award":["309\/2016\/FaF"],"award-info":[{"award-number":["309\/2016\/FaF"]}],"id":[{"id":"10.13039\/501100004755","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004755","name":"University of Veterinary and Pharmaceutical Sciences Brno","doi-asserted-by":"publisher","award":["2017-FaF-07"],"award-info":[{"award-number":["2017-FaF-07"]}],"id":[{"id":"10.13039\/501100004755","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.bioorg.2017.12.034","type":"journal-article","created":{"date-parts":[[2018,1,3]],"date-time":"2018-01-03T03:33:11Z","timestamp":1514950391000},"page":"25-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Novel sulfonamide incorporating piperazine, aminoalcohol and 1,3,5-triazine structural motifs with carbonic anhydrase I, II and IX inhibitory action"],"prefix":"10.1016","volume":"77","author":[{"given":"Eva","family":"Havr\u00e1nkov\u00e1","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jozef","family":"Cs\u00f6llei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Vullo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladim\u00edr","family":"Garaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavel","family":"Pazdera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2017.12.034_b0005","series-title":"Carbonic Anhydrase-Its Inhibitors and Activators","first-page":"253","article-title":"Cancer-related carbonic anhydrase isozymes","author":"Pastorekova","year":"2004"},{"key":"10.1016\/j.bioorg.2017.12.034_b0010","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/14756360410001689540","article-title":"Carbonic anhydrases: current state of the art, therapeutic applications and future prospects","volume":"19","author":"Pastorekova","year":"2008","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2017.12.034_b0015","doi-asserted-by":"crossref","first-page":"5427","DOI":"10.1016\/j.bmcl.2004.07.087","article-title":"Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic\/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties","volume":"14","author":"Garaj","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2017.12.034_b0020","doi-asserted-by":"crossref","first-page":"608R","DOI":"10.1152\/ajpregu.00538.2003","article-title":"HIFs and tumors\u2013causes and consequences","volume":"286","author":"H\u00f6pfl","year":"2004","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.bioorg.2017.12.034_b0025","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM197111182852108","article-title":"Tumor angiogenesis: therapeutic implications","volume":"285","author":"Folkman","year":"1971","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioorg.2017.12.034_b0030","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1128\/MCB.24.7.2875-2889.2004","article-title":"Hypoxia-mediated down-regulation of bid and bax in tumors occurs via hypoxia-inducible factor 1-dependent and -independent mechanisms and contributes to drug resistance","volume":"24","author":"Erler","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bioorg.2017.12.034_b0035","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2017.12.034_b0040","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1158\/0008-5472.CAN-10-4261","article-title":"Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors","volume":"71","author":"Lou","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2017.12.034_b0045","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1634\/theoncologist.9-90005-4","article-title":"Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response","volume":"9","author":"Vaupel","year":"2004","journal-title":"The Oncologist"},{"key":"10.1016\/j.bioorg.2017.12.034_b0050","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1042\/BCJ20160115","article-title":"Structure and function of carbonic anhydrases","volume":"473","author":"Supuran","year":"2016","journal-title":"Biochem. J."},{"key":"10.1016\/j.bioorg.2017.12.034_b0055","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1016\/j.bmcl.2005.04.056","article-title":"Carbonic anhydrase inhibitors: Novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX","volume":"15","author":"Garaj","year":"2005","journal-title":"Bioorg. Med. Cem. Lett."},{"key":"10.1016\/j.bioorg.2017.12.034_b0060","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.febslet.2004.10.043","article-title":"Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH","volume":"577","author":"\u0160vastov\u00e1","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bioorg.2017.12.034_b0065","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrd3554","article-title":"Interfering with pH regulation in tumours as a therapeutic strategy","volume":"10","author":"Neri","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2017.12.034_b0070","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/14756366.2015.1122001","article-title":"How many carbonic anhydrase inhibition mechanisms exist?","volume":"31","author":"Supuran","year":"2015","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2017.12.034_b0075","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3389\/fphys.2013.00400","article-title":"Carbonic anhydrase IX, a hypoxia-induced catalytic component of the pH regulating machinery in tumors","volume":"4","author":"Sedlakova","year":"2014","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bioorg.2017.12.034_b0080","first-page":"7075","article-title":"Hypoxia-inducible expression of tumor-associated carbonic anhydrases","volume":"60","author":"Wykoff","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2017.12.034_b0085","doi-asserted-by":"crossref","first-page":"E48","DOI":"10.3390\/metabo7030048","article-title":"Carbonic anhydrase inhibition and the management of hypoxic tumors","volume":"7","author":"Supuran","year":"2017","journal-title":"Metabolites."},{"key":"10.1016\/j.bioorg.2017.12.034_b0090","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1016\/j.bmc.2011.04.005","article-title":"Sulfonamides incorporating 1,3,5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms I and II: Solution and X-ray crystallographic studies","volume":"19","author":"Carta","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2017.12.034_b0095","doi-asserted-by":"crossref","first-page":"6929","DOI":"10.1016\/j.bmc.2013.09.031","article-title":"Inhibition of human carbonic anhydrase isoforms I-XIV with sulfonamides incorporating fluorine and 1,3,5-triazine moieties","volume":"21","author":"Ceruso","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2017.12.034_b0100","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.3390\/molecules21121649","article-title":"Phenols and polyphenols as carbonic anhydrase inhibitors","volume":"21","author":"Karioti","year":"2016","journal-title":"Molecules."},{"key":"10.1016\/j.bioorg.2017.12.034_b0105","doi-asserted-by":"crossref","first-page":"16233","DOI":"10.1073\/pnas.0908301106","article-title":"Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX","volume":"106","author":"Alterio","year":"2009","journal-title":"PNAS"},{"key":"10.1016\/j.bioorg.2017.12.034_b0110","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Sastry","year":"2013","journal-title":"J. Comput. Aid. Mol. Des."},{"key":"10.1016\/j.bioorg.2017.12.034_b0115","unstructured":"CombiGlide, version 3.8, Schr\u00f6dinger, LLC, New York, NY, 2015."},{"key":"10.1016\/j.bioorg.2017.12.034_b0120","unstructured":"LigPrep, version 3.5, Schr\u00f6dinger, LLC, New York, NY, 2015."},{"key":"10.1016\/j.bioorg.2017.12.034_b0125","unstructured":"Epik, version 3.3, Schr\u00f6dinger, LLC, New York, NY, 2015."},{"key":"10.1016\/j.bioorg.2017.12.034_b0130","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10822-007-9133-z","article-title":"Epik: a software program for pKa prediction and protonation state generation for druglike molecules","volume":"21","author":"Shelley","year":"2007","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.bioorg.2017.12.034_b0135","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10822-010-9349-1","article-title":"Towards the comprehensive, rapid, and accurate prediction of the favorable tautomeric states of drug-like molecules in aqueous solution","volume":"24","author":"Greenwood","year":"2010","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.bioorg.2017.12.034_b0140","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1016\/0005-2795(70)90020-6","article-title":"Sulphonamide complexes of human carbonic anhydrases ultraviolet difference spectroscopy","volume":"207","author":"King","year":"1970","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bioorg.2017.12.034_b0145","unstructured":"Glide, version 6.8, Schr\u00f6dinger, LLC, New York, NY, 2015."},{"key":"10.1016\/j.bioorg.2017.12.034_b0150","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2017.12.034_b0155","unstructured":"QM-Polarized Ligand Docking protocol 2015-3; Glide version 5.9, Jaguar version 8.0, QSite version 5.9, Schr\u00f6dinger, LLC, New York, NY, 2015."},{"key":"10.1016\/j.bioorg.2017.12.034_b0160","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/jcc.20222","article-title":"Importance of accurate charges in molecular docking: quantum mechanical\/molecular mechanical (QM\/MM) approach","volume":"25","author":"Cho","year":"2005","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2017.12.034_b0165","unstructured":"QikProp, version 4.5, Schr\u00f6dinger, LLC, New York, NY, 2015."},{"key":"10.1016\/j.bioorg.2017.12.034_b0170","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C","volume":"246","author":"Khalifah","year":"1971","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2017.12.034_b0175","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1021\/jm101541x","article-title":"Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase ix and show antimetastatic activity in a model of breast cancer metastasis","volume":"54","author":"Pacchiano","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2017.12.034_b0180","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1039\/c2cc16395k","article-title":"Dithiocarbamates: a new class of carbonic anhydrase inhibitors. Crystallographic and kinetic investigations","volume":"48","author":"Carta","year":"2012","journal-title":"Chem. Commun."},{"key":"10.1016\/j.bioorg.2017.12.034_b0185","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3109\/14756366.2011.641015","article-title":"Dithiocarbamates strongly inhibit the \u03b2-class carbonic anhydrases from Mycobacterium tuberculosis","volume":"28","author":"Maresca","year":"2013","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2017.12.034_b0190","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.bmcl.2011.12.033","article-title":"Dithiocarbamates are strong inhibitors of the beta-class fungal carbonic anhydrases from Cryptococcus neoformans, Candida albicans and Candida glabrata","volume":"22","author":"Monti","year":"2012","journal-title":"Bioor. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2017.12.034_b0195","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1021\/jm300031j","article-title":"Dithiocarbamates strongly inhibit carbonic anhydrases and show antiglaucoma action in vivo","volume":"55","author":"Carta","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2017.12.034_b0200","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.1021\/jm1003667","article-title":"Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule","volume":"53","author":"Carta","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2017.12.034_b0205","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.bmcl.2008.01.077","article-title":"Carbonic anhydrase inhibitors: Interactions of phenols with the 12 catalytically active mammalian isoforms (CA I-XIV)","volume":"18","author":"Innocenti","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2017.12.034_b0210","doi-asserted-by":"crossref","first-page":"7424","DOI":"10.1016\/j.bmc.2008.06.013","article-title":"Carbonic anhydrase inhibitors: Inhibition of mammalian isoforms I-XIV with a series of substituted phenols including paracetamol and salicylic acid","volume":"16","author":"Innocenti","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2017.12.034_b0215","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bmc.2009.11.021","article-title":"Carbonic anhydrase inhibitors. Identification of selective inhibitors of the human mitochondrial isozymes VA and VB over the cytosolic isozymes I and II from a natural product-based phenolic library","volume":"18","author":"Davis","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2017.12.034_b0220","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1021\/jm1013242","article-title":"Natural product-based phenols as novel probes for mycobacterial and fungal carbonic anhydrases","volume":"54","author":"Davis","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2017.12.034_b0225","doi-asserted-by":"crossref","first-page":"8838","DOI":"10.1039\/c2cc34275h","article-title":"Hydroxamate represents a versatile zinc binding group for the development of new carbonic anhydrase inhibitors","volume":"48","author":"Di Fiore","year":"2012","journal-title":"Chem. Comm."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206817307642?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206817307642?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T07:43:42Z","timestamp":1758613422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206817307642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":45,"alternative-id":["S0045206817307642"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2017.12.034","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel sulfonamide incorporating piperazine, aminoalcohol and 1,3,5-triazine structural motifs with carbonic anhydrase I, II and IX inhibitory action","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2017.12.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}